Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005129 · ClinicalTrials.gov registry record

Bogalusa Heart Study

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by Tulane University.

Active
Registry status
11,737
Enrollment target
1
Study location

NCT00005129 is a study of Hypertension and Cardiovascular Diseases that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 11,737 participants, above the 3,482-participant average among 470 other Hypertension trials with a reported enrollment target (237% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005129, a study of Hypertension and Cardiovascular Diseases, is active but no longer recruiting, sponsored by Tulane University.

ACTIVE NOT RECRUITING
Registry status
11,737 participants
Enrollment target
1
Study location

Study Summary

To determine the natural history of atherosclerosis, coronary artery disease, and hypertension in children and adults from birth through mid-life in a total biracial community.

Study Locations (1)

Louisiana

  • Tulane University - New Orleans

Trial Details

FieldValue
Enrollment Target 11,737 participants
Start Date 1973-08
Est. Completion 2029-11

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT00005129

The ClinicalTrials.gov registry entry for NCT00005129 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 11,737 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,482-participant average among 470 other Hypertension trials with a reported enrollment target (237% higher). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00005129 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT00005129 about?

NCT00005129 is a clinical study titled "Bogalusa Heart Study". To determine the natural history of atherosclerosis, coronary artery disease, and hypertension in children and adults from birth through mid-life in a total biracial community.

What is the current status of trial NCT00005129?

This trial is currently active not recruiting. The enrollment target is 11,737 participants. The study started on 1973-08. Estimated completion is 2029-11.

What conditions does trial NCT00005129 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Disease.

Who is sponsoring clinical trial NCT00005129?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005129 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.